25433-13-0 Usage
Uses
Used in Pharmaceutical Research and Development:
1-METHYL-5-PHENYL-1H-IMIDAZOLE-2-THIOL is used as a key intermediate in the synthesis of various pharmaceuticals for its potent biological activities. Its antifungal and antibacterial properties make it a promising candidate for the development of new drugs to combat infections.
Used in Anticancer Applications:
In the field of oncology, 1-METHYL-5-PHENYL-1H-IMIDAZOLE-2-THIOL is being studied for its potential use in treating cancer. Its biological activities suggest that it may have therapeutic effects against various types of cancer, warranting further research into its mechanisms of action and potential synergistic effects with existing treatments.
Used in Antioxidant and Anti-inflammatory Therapies:
1-METHYL-5-PHENYL-1H-IMIDAZOLE-2-THIOL is also being investigated for its antioxidant and anti-inflammatory properties. These characteristics indicate its potential use in the development of therapies for conditions associated with oxidative stress and inflammation, such as neurodegenerative diseases and autoimmune disorders.
Used in Organic Synthesis:
As a chemical compound with unique structural features, 1-METHYL-5-PHENYL-1H-IMIDAZOLE-2-THIOL is utilized in organic synthesis for the creation of new molecules with potential applications in various industries, including pharmaceuticals, materials science, and agrochemicals. Its versatility in synthesis contributes to the discovery of novel compounds with specific functions and properties.
Check Digit Verification of cas no
The CAS Registry Mumber 25433-13-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,5,4,3 and 3 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 25433-13:
(7*2)+(6*5)+(5*4)+(4*3)+(3*3)+(2*1)+(1*3)=90
90 % 10 = 0
So 25433-13-0 is a valid CAS Registry Number.
InChI:InChI=1/C10H10N2S/c1-12-9(7-11-10(12)13)8-5-3-2-4-6-8/h2-7H,1H3,(H,11,13)
25433-13-0Relevant academic research and scientific papers
Methimazole derivatives and tautomeric cyclic thiones to treat autoimmune diseases
-
, (2008/06/13)
The present invention provides methods for treating autoimmune diseases in mammals and for preventing or treating transplantation rejection in a transplant recipient. These methods utilize specifically-defined methimazole derivatives and tautomeric cyclic
